Skip to main content
GENB logo

GENB · Generate Biomedicines, Inc. · Financials

Track GENB — free
$9.54 -0.83 (-8.00%) At close · Nov 20
Market Cap
$1.23B
Shares
129.10M
Volume · Nov 20 967.86K Avg daily vol (3M) 1.23M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Chart any reported metric, KPI or segment over time — the full statement history lives here

No structured figures reported for this view yet.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current finance lease liabilities 2026-09-30 USD 12,499,000 10-Q filed 2026-11-12
Current operating lease liabilities 2026-09-30 USD 10,830,000 10-Q filed 2026-11-12
Noncurrent finance lease liabilities 2026-09-30 USD 5,891,000 10-Q filed 2026-11-12
Noncurrent operating lease liabilities 2026-09-30 USD 46,121,000 10-Q filed 2026-11-12
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
—
Peer median 7.56×
EV/EBIT
—
Peer median 18.67×
P/E (TTM)
—
Peer median 11.15×
Price/Sales (TTM)
—
Peer median 9.82×
Price/Book
3.23×
Peer median 2.94×

Peer medians compare against the 288 similar-size Biotechnology companies (of 593 listed).

Valuation over time computed as of each quarter's filing date

Key facts CIK 2100782 CUSIP 370920100 13F (30d) 100 filings 98 filers Visit website Investor relations